Literature DB >> 29022889

ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II).

S M C De Sousa1,2,3, M Stowasser4, J Feng5, A W Schreiber5,6, P Wang5, C N Hahn2,3, R D Gordon4, D J Torpy1,2, H S Scott2,3,5,6,7, L Gagliardi1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29022889     DOI： 10.1038/jhh.2017.71

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  14 in total

1.  ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia.

Authors:  Lucia Gagliardi; Andreas W Schreiber; Christopher N Hahn; Jinghua Feng; Treena Cranston; Hannah Boon; Cheri Hotu; Bergithe E Oftedal; Richard Cutfield; David L Adelson; Wilton J Braund; Richard D Gordon; D Aled Rees; Ashley B Grossman; David J Torpy; Hamish S Scott
Journal:  J Clin Endocrinol Metab       Date:  2014-06-06       Impact factor: 5.958

2.  Primary Aldosteronism and ARMC5 Variants.

Authors:  Mihail Zilbermint; Paraskevi Xekouki; Fabio R Faucz; Annabel Berthon; Alexandra Gkourogianni; Marie Helene Schernthaner-Reiter; Maria Batsis; Ninet Sinaii; Martha M Quezado; Maria Merino; Aaron Hodes; Smita B Abraham; Rossella Libé; Guillaume Assié; Stéphanie Espiard; Ludivine Drougat; Bruno Ragazzon; Adam Davis; Samson Y Gebreab; Ryan Neff; Electron Kebebew; Jérôme Bertherat; Maya B Lodish; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-03-30       Impact factor: 5.958

3.  Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms).

Authors:  Paolo Mulatero; Davide Tizzani; Andrea Viola; Chiara Bertello; Silvia Monticone; Giulio Mengozzi; Domenica Schiavone; Tracy Ann Williams; Silvia Einaudi; Antonio La Grotta; Franco Rabbia; Franco Veglio
Journal:  Hypertension       Date:  2011-08-29       Impact factor: 10.190

4.  A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).

Authors:  A R Lafferty; D J Torpy; M Stowasser; S E Taymans; J P Lin; P Huggard; R D Gordon; C A Stratakis
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

5.  ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.

Authors:  Guillaume Assié; Rossella Libé; Stéphanie Espiard; Marthe Rizk-Rabin; Anne Guimier; Windy Luscap; Olivia Barreau; Lucile Lefèvre; Mathilde Sibony; Laurence Guignat; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Franck Letourneur; Bilal Trabulsi; Alix Poussier; Nathalie Chabbert-Buffet; Françoise Borson-Chazot; Lionel Groussin; Xavier Bertagna; Constantine A Stratakis; Bruno Ragazzon; Jérôme Bertherat
Journal:  N Engl J Med       Date:  2013-11-28       Impact factor: 91.245

6.  Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.

Authors:  M Stowasser; R D Gordon; T J Tunny; S A Klemm; W L Finn; A L Krek
Journal:  Clin Exp Pharmacol Physiol       Date:  1992-05       Impact factor: 2.557

7.  A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.

Authors:  N M Albiger; D Regazzo; B Rubin; A M Ferrara; S Rizzati; E Taschin; F Ceccato; G Arnaldi; F Pecori Giraldi; A Stigliano; L Cerquetti; F Grimaldi; E De Menis; M Boscaro; M Iacobone; G Occhi; C Scaroni
Journal:  Endocrine       Date:  2016-04-19       Impact factor: 3.633

8.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

9.  Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.

Authors:  D J Torpy; R D Gordon; J P Lin; P R Huggard; S E Taymans; M Stowasser; G P Chrousos; C A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

10.  ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions.

Authors:  P Mulatero; F Schiavi; T A Williams; S Monticone; G Barbon; G Opocher; F Fallo
Journal:  J Hum Hypertens       Date:  2015-10-08       Impact factor: 3.012
View more
  2 in total

Review 1.  Genetic Testing in Endocrinology.

Authors:  Sunita Mc De Sousa; Tristan Se Hardy; Hamish S Scott; David J Torpy
Journal:  Clin Biochem Rev       Date:  2018-02

2.  Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology.

Authors:  Constantine A Stratakis; Annabel Berthon
Journal:  Curr Opin Endocr Metab Res       Date:  2019-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.